Order Article Reprints

Stanowska O, Kuczkiewicz-Siemion O, Dębowska M, Olszewski WP, Jagiełło-Gruszfeld A, Tysarowski A, Prochorec-Sobieszek M. PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters. Journal of Clinical Medicine. 2022; 11(19):5524. https://doi.org/10.3390/jcm11195524

Stanowska, Olga, Olga Kuczkiewicz-Siemion, Małgorzata Dębowska, Wojciech P. Olszewski, Agnieszka Jagiełło-Gruszfeld, Andrzej Tysarowski, and Monika Prochorec-Sobieszek. 2022. "PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters" Journal of Clinical Medicine 11, no. 19: 5524. https://doi.org/10.3390/jcm11195524

Stanowska, O., Kuczkiewicz-Siemion, O., Dębowska, M., Olszewski, W. P., Jagiełło-Gruszfeld, A., Tysarowski, A., & Prochorec-Sobieszek, M. (2022). PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters. Journal of Clinical Medicine, 11(19), 5524. https://doi.org/10.3390/jcm11195524